Epic Systems and several healthcare providers have sued Health Gorilla and other companies, alleging they exploited ...
AI rivals Anthropic and OpenAI are both expanding their large language models into healthcare. Anthropic is blending its enterprise and consumer tools in a single platform, while OpenAI is separating ...
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology has technology that could broaden the reach of this type ...
Costs for employer-sponsored health insurance surged from 2023 to 2024, rising faster than inflation, according to a new analysis. The report was conducted by researchers from the State Health Access ...
Cancer care company Color Health is partnering with insurer Evry Health to enhance employer health plans with its cancer care services, according to a Wednesday announcement. Evry Health is a ...
Human relationships are and always will be the crux of meaningful customer engagements in the pharmaceutical industry. No channel rivals the impact of a well-prepared, well-supported representative.
Metabolic medicines continue to be one of the hottest areas for drug research, so it should come as no surprise that deal flow for obesity and diabetes drugs was a particular highlight of biopharma ...
As demand for GLP-1s skyrockets, employers are struggling with the cost to cover these expensive medications for their employees. That’s why the Peterson Health Technology Institute, an independent ...
Even with significant educational efforts, heart disease remains the leading cause of death in the US and worldwide—for both men and women. While statins are the standard of care, Esperion ...
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...
According to one expert at Pitchbook, two core issues are likely to dominate healthcare reform discussions in 2026: rising costs and flaws in Medicare Advantage. Healthcare affordability remains a ...
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding ...